Akiko Miyagi Maeshima

Summary

Affiliation: National Cancer Center
Country: Japan

Publications

  1. doi request reprint Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy
    Akiko Miyagi Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, 104 0045 Tokyo, Japan Electronic address
    Hum Pathol 44:2529-35. 2013
  2. doi request reprint Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma
    Akiko M Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer Sci 104:952-7. 2013
  3. doi request reprint Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma
    Mayumi Oyama
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 43:540-6. 2013
  4. doi request reprint Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy
    Akiko M Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Am J Surg Pathol 37:563-70. 2013
  5. doi request reprint Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy
    Akiko Miyagi Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer Sci 103:1898-904. 2012
  6. doi request reprint Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status
    Akiko Miyagi Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer 118:4512-8. 2012
  7. doi request reprint Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
    Akiko Miyagi Maeshima
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer Sci 100:54-61. 2009
  8. doi request reprint Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator
    Akiko Miyagi Maeshima
    Clinical Laboratory Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuoku, 104 0045 Tokyo, Japan
    J Thorac Oncol 5:333-9. 2010
  9. doi request reprint Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence
    Akiko Miyagi Maeshima
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    J Thorac Oncol 5:466-71. 2010
  10. doi request reprint Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung
    Akiko Miyagi Maeshima
    Clinical Laboratory and double daggerThoracic Surgery Divisions, National Cancer Center Hospital, Tokyo, Japan
    J Thorac Oncol 3:698-703. 2008

Collaborators

Detail Information

Publications34

  1. doi request reprint Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy
    Akiko Miyagi Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, 104 0045 Tokyo, Japan Electronic address
    Hum Pathol 44:2529-35. 2013
    ..Bcl-2 expression and marginal zone differentiation were not prognostic indicators in follicular lymphoma patients treated with rituximab-containing therapy. ..
  2. doi request reprint Clinicopathological prognostic indicators in 107 patients with diffuse large B-cell lymphoma transformed from follicular lymphoma
    Akiko M Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer Sci 104:952-7. 2013
    ..Thus, asynchronism and 100% proportion of DLBCL, that is, FL relapsed as pure DLBCL, or FL and DLBCL at different sites, were significant predictors of unfavorable outcome of patients with DLBCL transformed from FL...
  3. doi request reprint Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma
    Mayumi Oyama
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 43:540-6. 2013
    ..This study aimed to verify the prognostic impact of pleural invasion according to the revised TNM classification, seventh edition...
  4. doi request reprint Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy
    Akiko M Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Am J Surg Pathol 37:563-70. 2013
    ..As the changes in morphology and CD20 expression after rituximab therapy vary widely, careful follow-up and rebiopsy are recommended...
  5. doi request reprint Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy
    Akiko Miyagi Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer Sci 103:1898-904. 2012
    ..In conclusion, Bcl-2 positivity, Bcl-6 negativity, and higher IPI were indicators of shorter PFS and OS plus primary refractory disease in patients with DLBCL in the rituximab era...
  6. doi request reprint Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status
    Akiko Miyagi Maeshima
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer 118:4512-8. 2012
    ....
  7. doi request reprint Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
    Akiko Miyagi Maeshima
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Cancer Sci 100:54-61. 2009
    ..In conclusion, B-NHL showed various histological and immunophenotypic changes after rituximab therapy, including not only CD20 loss but also proliferation of plasmacytoid cells or transformation to special subtypes of lymphoma...
  8. doi request reprint Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator
    Akiko Miyagi Maeshima
    Clinical Laboratory Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuoku, 104 0045 Tokyo, Japan
    J Thorac Oncol 5:333-9. 2010
    ..Lung adenocarcinomas 2 cm or less in diameter were studied to develop histologic criteria predicting the outcome...
  9. doi request reprint Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence
    Akiko Miyagi Maeshima
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    J Thorac Oncol 5:466-71. 2010
    ..Clarification of the clinicopathologic characteristics of patients with multiple atypical adenomatous hyperplasias (AAHs)...
  10. doi request reprint Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung
    Akiko Miyagi Maeshima
    Clinical Laboratory and double daggerThoracic Surgery Divisions, National Cancer Center Hospital, Tokyo, Japan
    J Thorac Oncol 3:698-703. 2008
    ..As there is little information on the histologic characteristics of adenocarcinoma in smokers, we histologically examined the effect of smoking on the carcinogenesis and progression of peripheral small lung adenocarcinomas...
  11. doi request reprint Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses
    Akiko Miyagi Maeshima
    Clinical Laboratory, National Cancer Center Hospital, Tsukiji 5 1 1, Chuo Ku, Tokyo 104 0045, Japan
    Cancer Sci 99:1760-8. 2008
    ..BCL6 translocation was detected in 1/6 (17%) DLBCLs without IGH/BCL2 fusion. Thus, although the morphological features and FISH results for DLBCL were consistent with transformed FL, the immunophenotype showed wide heterogeneity...
  12. ncbi request reprint Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung
    Tomoya Fukui
    Clinical Laboratory Division, National Cancer Center Hospital, 5 1 1 Tsukuji, Chuo Ku, Tokyo, Japan
    Cancer Sci 98:1714-9. 2007
    ..In addition to the clinicopathological characteristics of this rare histological type of lung cancer, these findings provide useful information for better understanding the biology, natural history and clinical management of SCLC...
  13. doi request reprint Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases
    Kazuhiro Sentani
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Jpn J Clin Oncol 38:547-52. 2008
    ..Follicular lymphomas (FLs) occur commonly in the lymph nodes, and duodenal FL (DFL) is reported to be rare...
  14. doi request reprint Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome)
    Akiko Miyagi Maeshima
    Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan
    Am J Clin Pathol 131:339-46. 2009
    ..Groups 1 and 2 showed the gain of CD5 during the clinical course or transformation of the tumors, suggesting that CD5 expression is closely associated with the progression of B-cell lymphoma...
  15. doi request reprint Comparison of different clones (WT49 versus 6F-H2) of WT-1 antibodies for immunohistochemical diagnosis of malignant pleural mesothelioma
    Koji Tsuta
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Appl Immunohistochem Mol Morphol 17:126-30. 2009
    ..Furthermore, the positive reaction of clone WT49 was restricted to nucleus without cytoplasmic staining, which is seen in conventionally used WT-1 antibodies...
  16. doi request reprint Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
    Dai Maruyama
    Hematology Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    Int J Hematol 92:732-43. 2010
    ..In conclusion, our modified CODOX-M/IVAC regimen is well tolerated and highly effective in Japanese adult patients with BL and intermediate DLBCL/BL, warranting a larger study for confirmation...
  17. doi request reprint Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis
    Naobumi Tochigi
    Pathology Division, National Cancer Center Research Institute, Tokyo 104 0045, Japan
    Ann Diagn Pathol 15:207-12. 2011
    ....
  18. doi request reprint Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation
    Wataru Munakata
    Departments of Hematology and Hematopoietic Stem Cell Transplantation, Division of Thoracic Surgery, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Am J Surg Pathol 36:1376-84. 2012
    ..Our observations suggest that transfused peripheral blood cells may be involved in the development of cancers after allogeneic peripheral blood stem cell transplantation...
  19. ncbi request reprint Primary ocular adnexal MALT lymphoma: a long-term follow-up study of 114 patients
    Kazuki Tanimoto
    Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital and Research Institute, Tokyo, Japan
    Jpn J Clin Oncol 37:337-44. 2007
    ....
  20. ncbi request reprint Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype"
    Shigeru Kusumoto
    Hematology Division, National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
    Am J Surg Pathol 29:1067-73. 2005
    ..The DLBCLs with Bcl-2 protein overexpression were classified into at least two heterogeneous molecular groups, based on the results of the FISH analysis...
  21. pmc Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma
    Junko Nomoto
    Hematology Division, National Cancer Center Hospital, Tokyo, Japan
    BMC Cancer 12:457. 2012
    ..However, the detection of this in primary Hodgkin lymphoma (HL) specimens is hampered by the scarcity of Hodgkin Reed-Sternberg (HR-S) cells even after enrichment by micro-dissection...
  22. pmc Fluorescence in situ hybridization (FISH) analysis of primary ocular adnexal MALT lymphoma
    Kazuki Tanimoto
    Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, Japan
    BMC Cancer 6:249. 2006
    ....
  23. doi request reprint Follicular lymphoma with marked monocytoid or plasmacytoid differentiation and tiny or indistinct follicles: a case study of four patients
    Kenji Yamada
    Pathology Division, National Cancer Center Hospital, Tokyo, Japan
    Leuk Lymphoma 52:804-13. 2011
    ..Identifying tiny CD10+/BCL-2+ neoplastic follicles, detecting IGH/BCL2 fusion by FISH, and considering a history of FL are crucial for diagnosing such exceptional cases of FL...
  24. doi request reprint Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors
    Yuji Takeda
    Clinical Laboratory Department, National Cancer Center Hospital, 1 1 Tsukiji 5 chome, Chuo Ku, Tokyo 104 0045, Japan
    Arch Pathol Lab Med 132:239-43. 2008
    ..Although it is often difficult to make a clear-cut differential diagnosis between the two, distinguishing primary lung carcinoma from breast carcinoma metastatic to the lung is important because the treatment modalities are different...
  25. ncbi request reprint Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung
    Akiko Miyagi Maeshima
    Pathology Division, National Cancer Center Research Institute, Tokyo, Japan
    Lung Cancer 52:53-8. 2006
    ..The aim of this study is to identify clinicopathologic prognostic factors...
  26. doi request reprint Cytological features of signet-ring cell carcinoma of the lung: comparison with the goblet-cell-type adenocarcinoma of the lung
    Koji Tsuta
    Division of Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Diagn Cytopathol 37:159-63. 2009
    ..The cytological features of SRCC were the presence of single tumor cells and nuclear pleomorphism, whereas that of GCA were the presence of abundant mucin and significant inflammation in the background, and a honeycomb-like cluster...
  27. ncbi request reprint Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma
    Yasufumi Kato
    Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Mod Pathol 20:215-20. 2007
    ..On the other hand, no RM cases were positive for GLUT-1. GLUT-1 is a sensitive and specific immunohistochemical marker enabling differential diagnosis of RM from MPM, whereas it cannot discriminate MPM from lung carcinoma...
  28. doi request reprint Clinicopathological analysis of primary lung carcinoma with heterotopic ossification
    Hidehiko Kuribayashi
    Clinical Laboratory Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    Lung Cancer 64:160-5. 2009
    ..The present study suggested that IHO associated with adenocarcinomas and BMP-2 production in the tumor cells, whereas EHO was not associated with the biology of the carcinoma...
  29. doi request reprint Combined high-grade neuroendocrine carcinoma of the lung: Clinicopathological and immunohistochemical study of 34 surgically resected cases
    Kenji Yamada
    Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan
    Pathol Int 64:28-33. 2014
    ..AD markers, but not SQ markers, were frequently retained through development of the HGNEC component. ..
  30. ncbi request reprint Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis
    Kiyoaki Nomoto
    Clinical Laboratory Division, National Cancer Center Hospital, Tokyo, Japan
    Am J Clin Pathol 126:608-15. 2006
    ..The sensitivity of this analysis was 90% (19/21) and specificity, 100% (15/15). These results suggest that HRMA of archived cytologic specimens of advanced NSCLC is useful for detecting EGFR mutations in clinical practice...
  31. doi request reprint Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation
    Shintaro Fukushima
    Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo, 104 0045, Japan
    Brain Tumor Pathol 31:11-6. 2014
    ..Although diagnostic utility of this marker awaits future exploration, actinin-4 may help distinguish between astrocytic and oligodendroglial lines of differentiation. ..
  32. doi request reprint A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy
    Seiichiro Abe
    Endoscopy Division, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
    Jpn J Clin Oncol 43:917-22. 2013
    ..The aim of this retrospective study was to evaluate the long-term outcomes of radiotherapy for localized gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication...
  33. ncbi request reprint Two entities of precursor T-cell lymphoblastic leukemia/lymphoma based on radiologic and immunophenotypic findings
    Yasushi Onishi
    Hematology Division, National Cancer Center Hospital, Tsukiji, Chou ku, Tokyo, Japan
    Int J Hematol 80:43-51. 2004
    ..This study was performed in a single institution, was retrospective, and had a limited number of patients; multicenter confirmatory studies are warranted...
  34. doi request reprint Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma
    Kohei Tada
    Department of Hematology and Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
    Am J Hematol 87:770-5. 2012
    ..These results suggest that allo-HCT may be a promising option for patients with not only advanced FL but also DLBCL associated with FL...